English
Home > Products > 18618-55-8

China 18618-55-8 Factory

We always think and practice corresponding to the change of circumstance, and grow up. We goal at the achievement of a richer mind and body and also the living for 18618-55-8,CAS NO 18618-55-8,CERIUM(III) CHLORIDE HEPTAHYDRATE, For additional facts, please make contact with us as shortly as possible!
18618-55-8, Insisting over the high-quality generation line management and prospects guide provider, we have made our resolution to offer our shoppers using the initially stage purchasing and soon after provider working experience. Preserving the prevailing helpful relations with our prospects, we even now innovate our product lists the many time to meet up with the brand new wants and stick to the latest trend of this business in Ahmedabad. We're ready to facial area the difficulties and make the transform to grasp many of the possibilities in international trade.

Related Products

Hot Products

  • 3,5-Di-tert-butylsalicylaldehyde

    3,5-Di-tert-butylsalicylaldehyde

    Product Name:3,5-Di-tert-butylsalicylaldehyde
    Molecular Formula:C15H22O2
    Molecular Weight:234.33
    CAS Registry Number:37942-07-7
  • Benazepril hydrochloride

    Benazepril hydrochloride

    Product Name:Benazepril hydrochloride
    Molecular Formula:C24H29ClN2O5
    Molecular Weight;460.95
    CAS Registry Number;86541-74-4
  • Flumequine

    Flumequine

    Product Name:Flumequine
    Molecular Formula:C14H12FNO3
    Molecular Weight;261.25
    CAS Registry Number;42835-25-6
  • Rucaparib

    Rucaparib

    Product Name:Rucaparib camsylate
    Molecular Formula:C29H34FN3O5S
    Molecular Weight;555.6607632
    CAS Registry Number;1327258-57-0
  • 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline

    4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline

    Product Name:4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline
    Molecular Formula:C17H16N2O3
    Molecular Weight:296.32
    CAS Registry Number:190728-25-7
  • Magnesium trisilicate

    Magnesium trisilicate

    Product Name:Magnesium trisilicate
    Molecular Formula:H8MgOSi
    Molecular Weight;76.45
    CAS Registry Number;14987-04-3
  • Related Blog
  • Reviews

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 18618-55-8

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept